dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Braña Garcia, Irene |
dc.contributor.author | Longhi, Alessandra |
dc.contributor.author | Awada, Ahmad |
dc.contributor.author | Subbiah, Vivek |
dc.contributor.author | Boni, Valentina |
dc.contributor.author | Delord, Jean-Pierre |
dc.date.accessioned | 2022-09-09T07:38:05Z |
dc.date.available | 2022-09-09T07:38:05Z |
dc.date.issued | 2022-07-01 |
dc.identifier.citation | Subbiah V, Braña I, Longhi A, Boni V, Delord JP, Awada A, et al. Antitumor Activity of Lurbinectedin, a Selective Inhibitor of Oncogene Transcription, in Relapsed Ewing Sarcoma: Results of a Basket Phase II StudyAntitumor activity of lurbinectedin in relapsed ES. Clin Cancer Res. 2022 Jul 1;28(13):2762–70. |
dc.identifier.issn | 1557-3265 |
dc.identifier.uri | https://hdl.handle.net/11351/8089 |
dc.description | Sarcoma de Ewing; Lurbinectedina |
dc.language.iso | eng |
dc.publisher | American Association for Cancer Research |
dc.relation.ispartofseries | Clinical Cancer Research;28(13) |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Sarcoma d'Ewing - Tractament |
dc.subject | Ossos - Càncer - Tractament |
dc.subject | Oncogens |
dc.subject.mesh | Sarcoma, Ewing |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Bone Neoplasms |
dc.subject.mesh | Oncogenes |
dc.title | Antitumor Activity of Lurbinectedin, a Selective Inhibitor of Oncogene Transcription, in Patients with Relapsed Ewing Sarcoma: Results of a Basket Phase II Study |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1158/1078-0432.CCR-22-0696 |
dc.subject.decs | sarcoma de Ewing |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | neoplasias óseas |
dc.subject.decs | oncogenes |
dc.relation.publishversion | https://doi.org/10.1158/1078-0432.CCR-22-0696 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Subbiah V] The University of Texas MD Anderson Cancer Center, Houston, Texas. [Braña I] Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Longhi A] Istituti Ortopedici Rizzoli, Bologna, Italy. [Boni V] START Madrid–Centro Integral Oncologico Clara Campal, Hospital Universitario Madrid Sanchinarro, Madrid, Spain. [Delord JP] Institut Claudius Regaud, Toulouse, France. [Awada A] Institut Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium |
dc.identifier.pmid | 35486638 |
dc.identifier.wos | 000823311900001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |